AIF1 and cancer: In the current pan-cancer analysis, based on the TCGA and GTEx databases, the expression of AIF-1 was observed to be significantly upregulated in the majority of cancer types studied, including BRCA, CESC, ESCA, CHOL, GBM, HNSC, KIRC, LAML, LGG, LIHC, OV, PAAD, SKCM, STAD, TGCT, THCA, and UCS.